JP2003502341A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003502341A5 JP2003502341A5 JP2001503886A JP2001503886A JP2003502341A5 JP 2003502341 A5 JP2003502341 A5 JP 2003502341A5 JP 2001503886 A JP2001503886 A JP 2001503886A JP 2001503886 A JP2001503886 A JP 2001503886A JP 2003502341 A5 JP2003502341 A5 JP 2003502341A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- amino acid
- seq
- sequence
- mammal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108090000765 processed proteins & peptides Proteins 0.000 description 28
- 150000001413 amino acids Chemical class 0.000 description 13
- 241000124008 Mammalia Species 0.000 description 7
- 238000000034 method Methods 0.000 description 5
- 230000023105 myelination Effects 0.000 description 5
- 230000014511 neuron projection development Effects 0.000 description 5
- 125000003275 alpha amino acid group Chemical group 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 241000282412 Homo Species 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- -1 aromatic amino acid Chemical class 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007917 intracranial administration Methods 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13968599P | 1999-06-16 | 1999-06-16 | |
| US60/139,685 | 1999-06-16 | ||
| PCT/US2000/016760 WO2000077029A1 (en) | 1999-06-16 | 2000-06-16 | Retro-inverso peptides derived from leukemia inhibitory factor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011033594A Division JP2011144184A (ja) | 1999-06-16 | 2011-02-18 | 白血病阻害因子に由来するレトロ−インベルソなペプチド |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003502341A JP2003502341A (ja) | 2003-01-21 |
| JP2003502341A5 true JP2003502341A5 (enExample) | 2007-08-09 |
Family
ID=22487838
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001503886A Withdrawn JP2003502341A (ja) | 1999-06-16 | 2000-06-16 | 白血病阻害因子に由来するレトロ−インベルソなペプチド |
| JP2011033594A Pending JP2011144184A (ja) | 1999-06-16 | 2011-02-18 | 白血病阻害因子に由来するレトロ−インベルソなペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011033594A Pending JP2011144184A (ja) | 1999-06-16 | 2011-02-18 | 白血病阻害因子に由来するレトロ−インベルソなペプチド |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1183266A4 (enExample) |
| JP (2) | JP2003502341A (enExample) |
| AU (1) | AU5622700A (enExample) |
| CA (1) | CA2376474A1 (enExample) |
| IL (2) | IL147095A0 (enExample) |
| WO (1) | WO2000077029A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5571787A (en) | 1993-07-30 | 1996-11-05 | Myelos Corporation | Prosaposin as a neurotrophic factor |
| EP1267911A4 (en) * | 2000-03-03 | 2004-04-21 | Amrad Corp Ltd | TREATMENT METHOD |
| AU3713201A (en) * | 2000-03-03 | 2001-09-12 | Inst Medical W & E Hall | A method of treatment |
| CA2645245A1 (en) * | 2006-03-31 | 2007-10-11 | Queen's University At Kingston | Compositions and methods for treating atherosclerosis |
| KR20180029201A (ko) | 2015-05-18 | 2018-03-20 | 티씨알2 테라퓨틱스 인크. | 융합 단백질을 이용하는 tcr 리프로그래밍을 위한 조성물 및 방법 |
| JP7291396B2 (ja) | 2016-11-22 | 2023-06-15 | ティーシーアール２ セラピューティクス インク． | 融合タンパク質を用いたｔｃｒの再プログラミングのための組成物及び方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843892A (en) * | 1989-12-18 | 1998-12-01 | California Institute Of Technology | Stimulation of nerve growth and/or vitality |
| US5700909A (en) * | 1993-07-30 | 1997-12-23 | The Regents Of The University Of California | Prosaposin and cytokine-derived peptides |
| US6271196B1 (en) * | 1996-03-05 | 2001-08-07 | Regents Of The University Of Ca | Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| EP0979238A4 (en) * | 1997-03-05 | 2000-08-23 | Univ California | METHOD FOR HEALING NEUROPATHIC PAIN |
| US6458357B1 (en) * | 1997-09-09 | 2002-10-01 | Myelos Corporation | Retro-inverso neurotrophic and analgesic peptides |
-
2000
- 2000-06-16 WO PCT/US2000/016760 patent/WO2000077029A1/en not_active Ceased
- 2000-06-16 AU AU56227/00A patent/AU5622700A/en not_active Abandoned
- 2000-06-16 EP EP00941527A patent/EP1183266A4/en not_active Withdrawn
- 2000-06-16 JP JP2001503886A patent/JP2003502341A/ja not_active Withdrawn
- 2000-06-16 CA CA002376474A patent/CA2376474A1/en not_active Abandoned
- 2000-06-16 IL IL14709500A patent/IL147095A0/xx unknown
-
2001
- 2001-12-13 IL IL147095A patent/IL147095A/en not_active IP Right Cessation
-
2011
- 2011-02-18 JP JP2011033594A patent/JP2011144184A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6337319B1 (en) | μ-Selective opioid peptides | |
| JP3266311B2 (ja) | 新規ポリペプチドおよびこれを用いる抗ｈｉｖ剤 | |
| AU689181B2 (en) | Compounds with growth hormone releasing properties | |
| JP2002527052A5 (enExample) | ||
| JP2002523518A5 (enExample) | ||
| EP1197220A3 (en) | Therapeutic methods and compositions based on delta proteins and nucleic acids | |
| ATE293453T1 (de) | Verbindungen zur behandlung von sexuellen funktionsstörungen | |
| CA2115839A1 (en) | Hla-restricted hepatitis b virus ctl epitopes | |
| JPH10509428A (ja) | 活性依存性神経栄養因子の神経栄養ペプチド | |
| WO2003064458A8 (fr) | Derives peptidiques, leur preparation et leur application therapeutique et cosmetique | |
| PL189292B1 (pl) | Analog heptapeptydowy, środek farmacetyczny zawierający ten analog, zastosowanie analogu, zastosowanie środka farmacetycznego, sposób wytwarzania tego analogu oraz sposób wytwarzania środka farmacetycznego | |
| WO1996016982A3 (en) | Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof | |
| LV10962B (en) | New peptides | |
| JPWO1992004374A1 (ja) | 新規ポリペプチドおよびこれを用いる抗ｈｉｖ剤 | |
| WO1992004374A1 (fr) | Nouveau polypeptide et medicament anti-vih prepare a partir de ce polypeptide | |
| JP2003502341A5 (enExample) | ||
| WO2002020561A1 (en) | Novel polypeptides and anti-hiv drugs containing the same | |
| US6855692B2 (en) | Histogranin peptides and their analgesic use | |
| US5223485A (en) | Anaphylatoxin-receptor ligands | |
| WO2002058589A3 (en) | Agents and methods for promoting bone growth | |
| JP2002540769A5 (enExample) | ||
| US5079231A (en) | Immunostimulating peptides, a process for their preparation and pharmaceutical compositions containing them | |
| JP2002522512A5 (enExample) | ||
| DE59810043D1 (de) | Verfahren zur Herstellung eines pharmazeutisch aktiven Peptides | |
| JP2633369B2 (ja) | ペプチド |